We are investigating the fairness of the price of $62.00 per share in cash for which Stericycle, Inc. (Nasdaq: SRCL) (“Stericycle”) has agreed to be sold to Waste Management, Inc. (“WMI”). The sales price is below the price targets for Stericycle of at least two Wall Street analysts (source: TipRanks).
If you remain a Stericycle shareholder and question the fairness of the price, you may contact our firm to discuss your legal rights at no charge by completing and submitting the form below.
Why is there an investigation?
On June 3, 2024, Stericycle announced that it had agreed to be sold to WMI for $62.00 per share in cash.
“We are investigating whether the Stericycle Board of Directors acted in the best interests of Stericycle shareholders in approving the sale,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter. “This includes whether the price agreed upon is fair to Stericycle shareholders, as well as whether all material information regarding the transaction has been fully disclosed.”
Notably, according to TipRanks, the sales price of $62.00 per share is below the price target for Stericycle of:
- Michael E. Hoffman of Stifel Nicolaus ($75.00)
- Sean Dodge of RBC Capital ($69.00)